ALA: Advanced lead cell therapy to Phase 1 trials, narrowing net loss and maintaining strong cash reserves
ALA: Off-the-shelf CAR-iNKT therapy nears first patient dosing, targeting broad oncology and autoimmune markets
Astera Labs (ALAB) Is Up 6.7% After Strong AI Connectivity Expectations Ahead Of Q2 Earnings - Has The Bull Case Changed?
AltaGas says Q2 2026 earnings strength comes from higher LPG export volumes, margins and Pipestone II contribution
Tourmaline Q2 net earnings drop 64% to CAD 184.43 million; revenue slips 1% to CAD 1.49 billion